ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ANVS Annovis Bio Inc

12.96
0.22 (1.73%)
Last Updated: 10:38:27
Delayed by 15 minutes

Period:

Draw Mode:

Volume 76,413
Bid Price
Ask Price
News -
Day High 13.29

Low
5.42

52 Week Range

High
22.49

Day Low 12.55
Share Name Share Symbol Market Stock Type
Annovis Bio Inc ANVS NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.22 1.73% 12.96 10:38:27
Open Price Low Price High Price Close Price Previous Close
12.55 12.55 13.29 12.74
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
670 76,413 US$ 12.97 US$ 991,431 - 5.42 - 22.49
Last Trade Type Quantity Price Currency
10:38:07 15 US$ 12.96 USD

Annovis Bio (ANVS) Options Flow Summary

Overall Flow

Bearish

Net Premium

-302k

Calls / Puts

54.55%

Buys / Sells

183.33%

OTM / ITM

466.67%

Sweeps Ratio

0.00%

Annovis Bio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
133.41M 10.26M - 0 -56.2M -5.48 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Annovis Bio News

Date Time Source News Article
4/02/202406:30GlobeNewswire Inc.Annovis Bio Provides Corporate Updates and Reports Fourth..
2/28/202406:08IH Market NewsUS Stock Movers Before Market: Beyond Meat, eBay, First..
2/12/202413:00Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of..
2/01/202415:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
11/22/202315:27Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of..
11/21/202313:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/21/202313:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/21/202313:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/21/202313:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/08/202315:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202306:30Business WireAnnovis Bio Measures Novel Biomarkers in Plasma of..
11/01/202311:28Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ANVS Message Board. Create One! See More Posts on ANVS Message Board See More Message Board Posts

Historical ANVS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week9.1113.64999.0411.48300,4293.8542.26%
1 Month12.0013.64998.8611.24207,8530.968.00%
3 Months11.6413.64998.100110.61223,9101.3211.34%
6 Months7.9422.495.4211.36261,1305.0263.22%
1 Year14.8122.495.4211.40147,711-1.85-12.49%
3 Years23.70132.005.4244.03255,589-10.74-45.32%
5 Years9.10132.002.41833.71260,7573.8642.42%

Annovis Bio Description

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.

Your Recent History

Delayed Upgrade Clock